<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7514029\results\search\disease\results.xml">
  <result pre="Review : Medicine and Health Sciences : Medical Conditions :" exact="Infectious" post="Diseases : Viral Diseases: Influenza : Medicine and Health"/>
  <result pre=": Medicine and Health Sciences : Medical Conditions : Infectious" exact="Diseases" post=": Viral Diseases: Influenza : Medicine and Health Sciences"/>
  <result pre="and Health Sciences : Medical Conditions : Infectious Diseases :" exact="Viral" post="Diseases: Influenza : Medicine and Health Sciences : Medical"/>
  <result pre="Influenza : Medicine and Health Sciences : Medical Conditions :" exact="Infectious" post="Diseases : Infectious Disease Control : Vaccines: Viral Vaccines"/>
  <result pre=": Medicine and Health Sciences : Medical Conditions : Infectious" exact="Diseases" post=": Infectious Disease Control : Vaccines: Viral Vaccines :"/>
  <result pre="and Health Sciences : Medical Conditions : Infectious Diseases :" exact="Infectious" post="Disease Control : Vaccines: Viral Vaccines : Biology and"/>
  <result pre="Health Sciences : Medical Conditions : Infectious Diseases : Infectious" exact="Disease" post="Control : Vaccines: Viral Vaccines : Biology and Life"/>
  <result pre="Conditions : Infectious Diseases : Infectious Disease Control : Vaccines:" exact="Viral" post="Vaccines : Biology and Life Sciences : Microbiology :"/>
  <result pre="Vaccines : Biology and Life Sciences : Microbiology : Virology:" exact="Viral" post="Vaccines : Biology and life sciences : Organisms :"/>
  <result pre="sciences : Microbiology : Medical microbiology : Microbial pathogens :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses: Influenza A virus"/>
  <result pre="Pathology and laboratory medicine : Pathogens : Microbial pathogens :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses: Influenza A virus"/>
  <result pre=": Biology and life sciences : Organisms : Viruses :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses: Influenza A virus"/>
  <result pre="Sciences : Microbiology : Medical Microbiology : Microbial Pathogens :" exact="Viral" post="Pathogens : Orthomyxoviruses: Influenza Viruses : Medicine and Health"/>
  <result pre="Pathology and Laboratory Medicine : Pathogens : Microbial Pathogens :" exact="Viral" post="Pathogens : Orthomyxoviruses: Influenza Viruses : Biology and Life"/>
  <result pre=": Biology and Life Sciences : Organisms : Viruses :" exact="Viral" post="Pathogens : Orthomyxoviruses: Influenza Viruses : Biology and Life"/>
  <result pre=": Biology and Life Sciences : Microbiology : Microbial Evolution:" exact="Viral" post="Evolution : Biology and Life Sciences : Evolutionary Biology"/>
  <result pre="Sciences : Evolutionary Biology : Organismal Evolution : Microbial Evolution:" exact="Viral" post="Evolution : Biology and Life Sciences : Microbiology :"/>
  <result pre="Evolution : Biology and Life Sciences : Microbiology : Virology:" exact="Viral" post="Evolution : Medicine and Health Sciences : Epidemiology: Pandemics"/>
  <result pre="Spring, Maryland, United States[5], World Health Organization Collaborating Centre for" exact="Infectious" post="Disease Epidemiology and Control, School of Public Health, The"/>
  <result pre="Maryland, United States[5], World Health Organization Collaborating Centre for Infectious" exact="Disease" post="Epidemiology and Control, School of Public Health, The University"/>
  <result pre="interest and research at the intersection of immunology, epidemiology, and" exact="viral" post="evolution. While the current focus is on developing a"/>
  <result pre="topics where computational modeling could bring valuable evidence: immune imprinting," exact="viral" post="evolution, and transmission. We address the positive and negative"/>
  <result pre="the positive and negative consequences of imprinting, in which early" exact="childhood" post="exposure to influenza shapes and limits immune responses to"/>
  <result pre="exposure to influenza shapes and limits immune responses to future" exact="infections" post="via memory of conserved influenza antigens. However, the mechanisms"/>
  <result pre="implementation of these novel products. Important questions include how early" exact="childhood" post="influenza exposure limits immune responses to future influenza infections,"/>
  <result pre="to future influenza infections, how universal influenza vaccines could drive" exact="viral" post="evolution, and how these new vaccines could impact the"/>
  <result pre="explores the potential population-level consequences of universal vaccines on immunity," exact="viral" post="evolution, and transmission and identifies gaps in extant experimental"/>
  <result pre="views on the optimization of universal influenza vaccines and address" exact="disease" post="dynamics between and within hosts. Although influenza B viruses"/>
  <result pre="influenza A viruses and cause annual epidemics, our review is" exact="limited" post="to influenza A viruses since they are responsible for"/>
  <result pre="quantitative analyses of epidemiological and phylogenetic data and simulations of" exact="disease" post="dynamics under various epidemiological and intervention scenarios. Universal influenza"/>
  <result pre="remains a complex topic about which we only have a" exact="limited" post="understanding. Influenza A subtypes are classified based on their"/>
  <result pre="exposed to a variety of influenza strains throughout life, while" exact="periodic" post="cycling of influenza subtypes and strains shapes the immune"/>
  <result pre="prompting the theory that exposure to related H1N1 viruses in" exact="childhood" post="may have conferred long-lasting protective immunity [7]. This epidemiological"/>
  <result pre="cannot prevent infection. However, they can modulate the course of" exact="infection" post="by reducing viral titers, disease severity, duration of infection,"/>
  <result pre="However, they can modulate the course of infection by reducing" exact="viral" post="titers, disease severity, duration of infection, and onward transmission,"/>
  <result pre="can modulate the course of infection by reducing viral titers," exact="disease" post="severity, duration of infection, and onward transmission, as shown"/>
  <result pre="than other parts of the protein, or antibody responses to" exact="stable" post="epitopes on the HA head that can persist for"/>
  <result pre="detail, their putative population profiles, and their expected impact on" exact="disease" post="dynamics. The HA stem is a proposed target for"/>
  <result pre="via mechanisms like antibody-dependent cellular cytotoxicity, which do not block" exact="viral" post="entry into cells [36]. Due to these immune mechanisms,"/>
  <result pre="HA stem-based vaccine may be an infection-permissive or â€œleakyâ€� vaccine." exact="Immunological" post="imprinting Here, we use the term immunological imprinting to"/>
  <result pre="termâ€�Original Antigenic Sinâ€� (OAS) to describe how the first influenza" exact="infection" post="â€œgoverns the response to vaccination with other strainsâ€� [37]"/>
  <result pre="phenomenon is poorly understood. The first exposure to influenza in" exact="childhood" post="has been shown to generate a very narrow antibody"/>
  <result pre="cross-reactive at that site are circulating (Fig 2D). Early influenza" exact="infections" post="can therefore leave a lifelong imprint or â€œbiasâ€� in"/>
  <result pre="population-level surveillance data, particularly by comparing the risk of influenza" exact="infection" post="in birth cohorts imprinted by different influenza histories (Fig"/>
  <result pre="may generate lifelong antibody responses to conserved epitopes and offer" exact="partial" post="protection against certain zoonotic strains and pandemics, it may"/>
  <result pre="2009 pandemic H1N1 virus. When this region of H1N1 viruses" exact="acquired" post="substitutions during the 2013 to 2014 influenza epidemic, these"/>
  <result pre="2013 to 2014 influenza epidemic, these middle-aged cohorts experienced higher" exact="disease" post="burden than in prior seasons and responded more poorly"/>
  <result pre="2009 pandemic, relative to surrounding cohorts [51]. Modeling risk of" exact="infection" post="by birth year Computational models can be useful to"/>
  <result pre="to obtain. Recent analyses of the risk of seasonal influenza" exact="infection" post="have illuminated the role of birth year imprinting at"/>
  <result pre="(Fig 2C). Those primed by H1N1 (born before 1957) experience" exact="partial" post="protection against all seasonal influenza H1N1 viruses throughout life"/>
  <result pre="susceptibility and behavioral factors that drive the risk of influenza" exact="infection" post="and propensity to seek care and, in turn, affect"/>
  <result pre="infection. Because of this strict definition, a fraction of true" exact="infections" post="may be missed. In a Vietnamese cohort study, a"/>
  <result pre="children are considered high-transmitter groups for influenza, due to high" exact="susceptibility to" post="influenza, increased contacts, and long duration of viral shedding"/>
  <result pre="high susceptibility to influenza, increased contacts, and long duration of" exact="viral" post="shedding [60, 61]. Hence, large-scale pediatric immunization programs have"/>
  <result pre="if any, can be overcome later in life by subsequent" exact="infections" post="or vaccinations. Longitudinal birth cohort studies will be particularly"/>
  <result pre="conferred by conventional vaccines is weaker than that of natural" exact="infection" post="[16, 66]. If studies determine that OAS cannot be"/>
  <result pre="potentially due to decreased somatic hypermutation [57], reduced B cell" exact="clonal" post="diversity [67], or other aspects of immune senescence. Repeat"/>
  <result pre="influenza internal proteins NP and M1, M2, using multiple peptides," exact="viral" post="vectors, and DNA constructs are among the most advanced"/>
  <result pre="shown promise in eliciting CD4 and CD8 T-cell responses, reducing" exact="viral" post="shedding and symptoms, and producing broadly cross-reactive responses. However,"/>
  <result pre="to meet a predefined endpoint of reduction in incidence and" exact="viral" post="shedding [72]. It is plausible that an optimal universal"/>
  <result pre="to aid universal influenza vaccine development. Universal influenza vaccines and" exact="viral" post="evolution The evolution of influenza A viruses is notoriously"/>
  <result pre="be more likely to emerge in people with prolonged influenza" exact="infections" post="(for instance, in immune-compromised hosts) [75]. Intriguingly, de novo"/>
  <result pre="hosts were later observed to dominate globally [75]. Between hosts," exact="viral" post="evolution is promoted by longer serial chains of transmission"/>
  <result pre="to target conserved regions of the influenza virus, which show" exact="limited" post="genetic variability in circulating strains. However, restrictions on influenza"/>
  <result pre="where experimental evidence had suggested that resistance mutations would impair" exact="viral" post="fitness [80]. Influenza viruses evolve resistance to antiviral drugs"/>
  <result pre="vein, cytotoxic T lymphocyte (CTL)-escape variants are thought to be" exact="limited" post="by strong functional constraints and the high polymorphism of"/>
  <result pre="stem [85, 87, 88]. Stem escape mutants arise at a" exact="lower" post="frequency than head escape mutants [29], especially under polyclonal"/>
  <result pre="would fare on a population level, or in a different" exact="viral" post="genetic background. The capacity of influenza viruses to evolve"/>
  <result pre="vaccines, for multiple reasons [91]. Drugs are delivered therapeutically, when" exact="viral" post="diversity and pathogen populations within a host are high."/>
  <result pre="In contrast, prophylactic administration of vaccines typically prevents or limits" exact="infection" post="so that the potential to generate new virus variants"/>
  <result pre="on host cofactors (e.g., HLAs) that are intrinsically diverse, limiting" exact="viral" post="escape at the population level. Therefore, resistance is less"/>
  <result pre="to conventional vaccines, some universal vaccines will likely permit a" exact="limited" post="amount of infection and may not block onward transmission."/>
  <result pre="some universal vaccines will likely permit a limited amount of" exact="infection" post="and may not block onward transmission. A better understanding"/>
  <result pre="influenza in the community and, hence, reduce the probability of" exact="infection" post="in unvaccinated individuals (the so-called herd immunity effect). (2)"/>
  <result pre="(3) Additionally, as previously noted, a leaky vaccine allowing for" exact="viral" post="shedding and onward transmission could promote viral evolution away"/>
  <result pre="vaccine allowing for viral shedding and onward transmission could promote" exact="viral" post="evolution away from the immune sites targeted by the"/>
  <result pre="early stages of vaccine development or during licensure. In the" exact="absence of" post="direct information on transmission, identification of correlates would be"/>
  <result pre="of the population benefits of T-cell based vaccines have used" exact="viral" post="shedding data in ferrets vaccinated with NP+M2 recombinant adenovirus"/>
  <result pre="how transmissibility is affected by the intensity and duration of" exact="viral" post="shedding. Difficulties here relate to the putative nonlinear relationship"/>
  <result pre="[95, 96], the different assays used to measure shedding, whether" exact="infectious" post="viral titers are quantified (preferably by plaque assay or"/>
  <result pre="96], the different assays used to measure shedding, whether infectious" exact="viral" post="titers are quantified (preferably by plaque assay or TCID50,"/>
  <result pre="in pauci- and asymptomatic individuals infected with influenza, relative to" exact="symptomatic" post="individuals; however, the potential for onwards transmission remains unclear"/>
  <result pre="A potentially detrimental effect of a vaccine that considerably reduces" exact="disease" post="severity might be to increase influenza transmission outside of"/>
  <result pre="against existing formulations [99]. Related work in the context of" exact="respiratory" post="syncytial virus illustrates how different characteristics of candidate vaccines"/>
  <result pre="virus illustrates how different characteristics of candidate vaccines may affect" exact="disease" post="dynamics positively or negatively [100]. While more work needs"/>
  <result pre="1960s [101, 102]. More recent work suggests a correlation between" exact="secondary" post="attack rates in households and risk of influenza transmission"/>
  <result pre="attack rates in households and risk of influenza transmission by" exact="respiratory" post="droplets in ferrets, which is auspicious for predictive models"/>
  <result pre="United Kingdom generated much enthusiasm but has reported mixed-effects on" exact="disease" post="impact [109]. Routine influenza immunization programs have become well-established"/>
  <result pre="and immunologic conditions that increase or decrease the rate of" exact="viral" post="evolution and quantify the evolutionary constraints on the different"/>
  <result pre="the evolutionary constraints on the different regions of the virus." exact="Combined" post="with data from transmission studies in humans and animals,"/>
  <result pre="Maryland. We thank Bernard Lafont, National Institute of Allergy and" exact="Infectious" post="Diseases, National Institutes of Health, and Scott Hensley, University"/>
  <result pre="The Strategic Plan for the National Institute of Allergy and" exact="Infectious" post="Diseases. J Infect Dis218(3):347â€&quot;354. 10.1093/infdis/jiy10329506129 2ArinaminpathyN, RileyS, BarclayW, Saad-RoyCM,"/>
  <result pre="Acad Sci U S A109(8):3173â€&quot;3177. 10.1073/pnas.111334210922323589 6MontoAS (2002) Epidemiology of" exact="viral" post="respiratory infections. Am J Med112Suppl 6A:4Sâ€&quot;12S.11955454 7JacobsJH, et al."/>
  <result pre="Sci U S A109(8):3173â€&quot;3177. 10.1073/pnas.111334210922323589 6MontoAS (2002) Epidemiology of viral" exact="respiratory" post="infections. Am J Med112Suppl 6A:4Sâ€&quot;12S.11955454 7JacobsJH, et al. (2012)"/>
  <result pre="responses to influenza. Sci Transl Med7(316):316ra19210.1126/scitranslmed.aad052226631631 10XuR, et al. (2010)" exact="Structural" post="basis of preexisting immunity to the 2009 H1N1 pandemic"/>
  <result pre="KhakpourM, &amp;amp; KilbourneED (1968) Protective effects of specific immunity to" exact="viral" post="neuraminidase on influenza virus infection of mice. J Virol2(8):778â€&quot;786."/>
  <result pre="Protective effects of specific immunity to viral neuraminidase on influenza" exact="virus infection" post="of mice. J Virol2(8):778â€&quot;786. 10.1128/JVI.2.8.778-786.19685701819 15EichelbergerMC &amp;amp; WanH (2015)"/>
  <result pre="effects of specific immunity to viral neuraminidase on influenza virus" exact="infection" post="of mice. J Virol2(8):778â€&quot;786. 10.1128/JVI.2.8.778-786.19685701819 15EichelbergerMC &amp;amp; WanH (2015)"/>
  <result pre="Curr Top Microbiol Immunol386:275â€&quot;299. 10.1007/82_2014_39825033754 16ChenYQ, et al. (2018) Influenza" exact="Infection" post="in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies."/>
  <result pre="pandemic. J Infect Dis192(2):233â€&quot;248. 10.1086/43115015962218 18EpsteinSL (2006) Prior H1N1 influenza" exact="infection" post="and susceptibility of Cleveland Family Study participants during the"/>
  <result pre="19SridharS, et al. (2013) Cellular immune correlates of protection against" exact="symptomatic" post="pandemic influenza. Nat Med19(10):1305â€&quot;1312. 10.1038/nm.335024056771 20HaywardAC, et al. (2015)"/>
  <result pre="the human B cell response against 2009 pandemic H1N1 influenza" exact="virus infection." post="J Exp Med208(1):181â€&quot;193. 10.1084/jem.2010135221220454 28FergusonNM, GalvaniAP, &amp;amp; BushRM (2003)"/>
  <result pre="31KallewaardNL, et al. (2016) Structure and Function Analysis of an" exact="Antibody" post="Recognizing All Influenza A Subtypes. Cell166(3):596â€&quot;608. 10.1016/j.cell.2016.05.07327453466 32SuiJ, et"/>
  <result pre="universal influenza virus vaccine candidate confers protection against pandemic H1N1" exact="infection" post="in preclinical ferret studies. NPJ Vaccines2:2610.1038/s41541-017-0026-429263881 36DiLilloDJ, TanGS, PaleseP,"/>
  <result pre="responses in southern China. PLoS Pathog8(7):e100280210.1371/journal.ppat.100280222829765 39FonvilleJM, et al. (2014)" exact="Antibody" post="landscapes after influenza virus infection or vaccination. Science346(6212):996â€&quot;1000. 10.1126/science.125642725414313"/>
  <result pre="PLoS Pathog8(7):e100280210.1371/journal.ppat.100280222829765 39FonvilleJM, et al. (2014) Antibody landscapes after influenza" exact="virus infection" post="or vaccination. Science346(6212):996â€&quot;1000. 10.1126/science.125642725414313 40MontoAS, MaloshRE, PetrieJG, &amp;amp; MartinET"/>
  <result pre="Pathog8(7):e100280210.1371/journal.ppat.100280222829765 39FonvilleJM, et al. (2014) Antibody landscapes after influenza virus" exact="infection" post="or vaccination. Science346(6212):996â€&quot;1000. 10.1126/science.125642725414313 40MontoAS, MaloshRE, PetrieJG, &amp;amp; MartinET"/>
  <result pre="al. (2014) Humans and ferrets with prior H1N1 influenza virus" exact="infections" post="do not exhibit evidence of original antigenic sin after"/>
  <result pre="infections do not exhibit evidence of original antigenic sin after" exact="infection" post="or vaccination with the 2009 pandemic H1N1 influenza virus."/>
  <result pre="Clin Vaccine Immunol21(5):737â€&quot;746. 10.1128/CVI.00790-1324648486 42MeadeP, et al. (2020) Influenza Virus" exact="Infection" post="Induces a Narrow Antibody Response in Children but a"/>
  <result pre="42MeadeP, et al. (2020) Influenza Virus Infection Induces a Narrow" exact="Antibody" post="Response in Children but a Broad Recall Response in"/>
  <result pre="Lloyd-SmithJO (2016) Potent protection against H5N1 and H7N9 influenza via" exact="childhood" post="hemagglutinin imprinting. Science354(6313):722â€&quot;726. 10.1126/science.aag132227846599 47EpsteinSL (2018) Universal Influenza Vaccines:"/>
  <result pre="Science354(6313):706â€&quot;707. 10.1126/science.aak981627846592 49LindermanSL, et al. (2014) Potential antigenic explanation for" exact="atypical" post="H1N1 infections among middle-aged adults during the 2013â€&quot;2014 influenza"/>
  <result pre="49LindermanSL, et al. (2014) Potential antigenic explanation for atypical H1N1" exact="infections" post="among middle-aged adults during the 2013â€&quot;2014 influenza season. Proc"/>
  <result pre="et al. (2018) Pandemic Paradox: Early Life H2N2 Pandemic Influenza" exact="Infection" post="Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic."/>
  <result pre="(2018) Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced" exact="Susceptibility to" post="Death during the 2009 H1N1 Pandemic. mBio9(1):e02091â€&quot;17. 10.1128/mBio.02091-1729339427 52ArevaloP,"/>
  <result pre="Pandemic. mBio9(1):e02091â€&quot;17. 10.1128/mBio.02091-1729339427 52ArevaloP, McLeanHQ, BelongiaEA, &amp;amp; CobeyS (2019) Earliest" exact="infections" post="predict the age distribution of seasonal influenza A cases."/>
  <result pre="A cases. eLife. 2020; 9: e5006010.7554/eLife.5006032633233 53GosticK, et al. (2019)" exact="Childhood" post="immune imprinting to influenza A shapes birth year-specific risk"/>
  <result pre="study. J Virol. 93(21):e01150â€&quot;19. 10.1128/JVI.01150-1931434733 58CauchemezS, et al. (2012) Influenza" exact="infection" post="rates, measurement errors and the interpretation of paired serology."/>
  <result pre="et al. (2010) Effect of influenza vaccination of children on" exact="infection" post="rates in Hutterite communities: a randomized trial. Jama303(10):943â€&quot;950. 10.1001/jama.2010.25020215608"/>
  <result pre="Influenza Immunity in Children. https://www.niaid.nih.gov/news-events/niaid-announces-two-awards-multi-year-studies-influenza-immunity-children 66KimJH, et al. (2016) Prior" exact="infection" post="with influenza virus but not vaccination leaves a long-term"/>
  <result pre="Virulent Pathogens. PLoS Biol13(7):e100219810.1371/journal.pbio.100219826214839 80BloomJD, GongLI, &amp;amp; BaltimoreD (2010) Permissive" exact="secondary" post="mutations enable the evolution of influenza oseltamivir resistance. Science328(5983):1272â€&quot;1275."/>
  <result pre="10.1016/j.vaccine.2006.05.05116837112 85DoudMB, LeeJM, &amp;amp; BloomJD (2018) How single mutations affect" exact="viral" post="escape from broad and narrow antibodies to H1 influenza"/>
  <result pre="Reduction of influenza virus transmission from mice immunized against conserved" exact="viral" post="antigens is influenced by route of immunization and choice"/>
  <result pre="Vaccine36(32 Pt B):4910â€&quot;4918. 10.1016/j.vaccine.2018.06.05130037481 93PriceGE, LoCY, MisplonJA, &amp;amp; EpsteinSL (2014)" exact="Mucosal" post="immunization with a candidate universal influenza vaccine reduces virus"/>
  <result pre="in the ferret model. PLoS ONE7(8):e4330310.1371/journal.pone.004330322952661 98IpDK, et al. (2017)" exact="Viral" post="Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza"/>
  <result pre="Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus" exact="Infections" post="in the Community. Clin Infect Dis64(6):736â€&quot;742. 10.1093/cid/ciw84128011603 99SubramanianR, GrahamAL,"/>
  <result pre="et al. (2017) Predicting the relative impacts of maternal and" exact="neonatal" post="respiratory syncytial virus (RSV) vaccine target product profiles: A"/>
  <result pre="al. (2017) Predicting the relative impacts of maternal and neonatal" exact="respiratory" post="syncytial virus (RSV) vaccine target product profiles: A consensus"/>
  <result pre="modelling approach. Vaccine35(2):403â€&quot;409. 10.1016/j.vaccine.2016.10.07327914740 101AndrewesCH &amp;amp; GlowerRE (1941) Spread of" exact="infection" post="from the respiratory tract of the ferret. I. Transmission"/>
  <result pre="10.1016/j.vaccine.2016.10.07327914740 101AndrewesCH &amp;amp; GlowerRE (1941) Spread of infection from the" exact="respiratory" post="tract of the ferret. I. Transmission of influenza A"/>
  <result pre="Pathol22:91â€&quot;97. 102SchulmanJL &amp;amp; KilbourneED (1963) Experimental Transmission Of Influenza Virus" exact="Infection" post="In Mice. Ii. Some Factors Affecting The Incidence Of"/>
  <result pre="107CharuV, et al. (2011) Influenza-related mortality trends in Japanese and" exact="American" post="seniors: evidence for the indirect mortality benefits of vaccinating"/>
  <result pre="10.1093/infdis/122.1-2.165433709 109PebodyRG, et al. (2018) Uptake and impact of vaccinating" exact="primary" post="school-age children against influenza: experiences of a live attenuated"/>
  <result pre="Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus" exact="Infection" post="Reflects Early-Life Imprinting and Adaptation to the Infecting Virus."/>
  <result pre="Cohort Effects in Influenza Surveillance Data: Evidence That First Influenza" exact="Infection" post="Affects Later Influenza-Associated Illness. J Infect Dis220(5):820â€&quot;829. 10.1093/infdis/jiz20131053844 114DavenportFM,"/>
  <result pre="Dis220(5):820â€&quot;829. 10.1093/infdis/jiz20131053844 114DavenportFM, HennessyAV, FrancisT, &amp;amp; FabischW (1953) Epidemiologic and" exact="Immunologic" post="Significance of Age Distribution of Antibody to Antigenic Variants"/>
  <result pre="FabischW (1953) Epidemiologic and Immunologic Significance of Age Distribution of" exact="Antibody" post="to Antigenic Variants of Influenza Virus. Journal of Experimental"/>
  <result pre="On the Doctrine of Original Antigenic Sin. Proceedings of the" exact="American" post="Philosophical Society. 104(6):572â€&quot;578."/>
 </snippets>
</snippetsTree>
